ArticleCanadian journal of anaesthesia = Journal canadien d'anesthesie2025
Association of preoperative beta-blocker interruption on postoperative morbidity and mortality: a historical cohort study.
Article in Canadian journal of anaesthesia = Journal canadien d'anesthesie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeWe aimed to investigate the impact that patient-initiated beta-blocker interruption on the morning of surgery has on postoperative adverse outcomes.
methodsWe conducted a historical cohort study of consecutive patients undergoing elective surgical procedures at two hospitals belonging to a single academic institution from 2014 to 2018 in the Canadian province of Ontario. We used electronic medical records to identify the initial cohort and collect patient information, including medication interruption. These data were linked to administrative data holdings, which we used to capture study outcomes, including 30-day and 90-day mortality and a composite outcome representing several adverse events. We used logistic regression to evaluate between-group differences in study outcomes and included a covariate representing propensity for beta-blocker interruption.
resultsThe final cohort included 4,971 patients, 22.2% of whom experienced a preoperative beta-blocker interruption. As compared with patients who continued their medication, those with a beta-blocker interruption had significantly decreased odds of 30-day mortality (odds ratio [OR], 0.42; 95% confidence interval [CI], 0.18 to 1.00; P = 0.049) and 90-day mortality (OR, 0.51; 95% CI, 0.28 to 0.90; P = 0.02) in adjusted analyses. Following adjustment, beta-blocker interruption was not significantly associated with any of the secondary outcomes.
conclusionsResults from this study suggest that preoperative acute beta-blocker interruption is significantly associated with decreased 30-day and 90-day postoperative all-cause mortality. These data challenge the long-held assumption that patients on beta-blockers should continue these medications during the perioperative period and indicate that a proper controlled trial is needed to assess the impact of withholding beta-blockers prior to major surgery.
Indexed as
Identifiers
40993480What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.